Stocktoria

RESMED INC RMD

NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1995-06-01 · LEI

RESMED INC statistics & valuation

Market cap$29.1B
P / E20.7×
P / S5.6×
P / B4.9×
P / FCF17.5×
Dividend yield1.07%
Net margin27.2%
Return on equity23.5%
FCF margin32.3%
Net cash$551.1M
Net debt / EBITDA-0.3×
Enterprise value USD$28.5B
EV / EBITDA15.1×
Earnings yield EBIT/EV5.9%
Return on capital23.6%
Graham number -58.8%$93.10

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($93.10); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
19.20% 16.60% 13.50% 15.50% 21.00% 14.80% 21.80% 21.30% 21.80% 27.20% 2016201720182019202020212022202320242025
Gross margin (%)
58.00% 58.10% 57.00% 57.30% 58.10% 57.50% 56.60% 55.80% 56.70% 59.40% 2016201720182019202020212022202320242025
Operating margin (%)
23.30% 20.60% 23.20% 22.20% 27.40% 28.30% 28.00% 26.80% 28.20% 32.70% 2016201720182019202020212022202320242025
Return on equity (%)
20.80% 17.50% 15.30% 19.50% 24.90% 16.40% 23.20% 21.70% 21.00% 23.50% 2016201720182019202020212022202320242025
Shares outstanding
141.7M 142.5M 144.0M 144.5M 145.7M 146.5M 147.0M 147.5M 147.6M 147.3M 2016201720182019202020212022202320242025
Net debt ($)
$141.9M $256.7M $81.3M $1.11B $701.0M $348.1M $491.6M $1.20B $459.0M -$551.1M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
10.80% 9.90% 10.30% 9.80% 13.60% 10.00% 15.30% 13.30% 14.90% 17.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
26.60% 17.00% 18.90% 15.00% 23.90% 19.80% 6.00% 13.60% 27.80% 32.30% 2016201720182019202020212022202320242025
Debt / equity (×)
0.52× 0.55× 0.13× 0.61× 0.47× 0.22× 0.23× 0.35× 0.14× 0.11× 2016201720182019202020212022202320242025
EPS ($)
$2.49 $2.40 $2.19 $2.80 $4.27 $3.24 $5.30 $6.09 $6.92 $9.51 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

RESMED INC trades at about 23.8× earnings — below its 10-year norm (10-year range 27.7×–83.9×, median 45.4×).

23.8× 83.9×

Shaded band = 10-year range (27.7×–83.9×); dot = today's 23.8×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin59.4%56.7%55.8%56.6%57.5%58.1%57.3%57.0%58.1%58.0%
Operating margin32.7%28.2%26.8%28.0%28.3%27.4%22.2%23.2%20.6%23.3%
Net margin27.2%21.8%21.3%21.8%14.8%21.0%15.5%13.5%16.6%19.2%
FCF margin32.3%27.8%13.6%6.0%19.8%23.9%15.0%18.9%17.0%26.6%
Return on assets17.1%14.9%13.3%15.3%10.0%13.6%9.8%10.3%9.9%10.8%
Return on equity23.5%21.0%21.7%23.2%16.4%24.9%19.5%15.3%17.5%20.8%
Debt / equity0.11×0.14×0.35×0.23×0.22×0.47×0.61×0.13×0.55×0.52×
Current ratio3.442.593.122.801.732.532.062.084.572.23

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.